Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-24 @ 10:35 PM
NCT ID:
NCT01086735
Eligibility Criteria:
Inclusion Criteria:
* Hematological malignancy.
* Previous allogeneic hematopoietic stem cell transplantation.
* Relapse diagnosed at the molecular, cytogenetic, or cytological level.
* Failure of a previous stdILD or inclusion in first intention without previous stdDLI.
* Age \> 18 years and \< 70 years at the time of inclusion. For patients between 15 and 18 years of age, a case-per case inclusion will be studied.
* Performance status considered on the score Eastern Cooperative Oncology Group (ECOG) \< 2.
* Life expectation 1-month-old superior.
* Signed written informed consent.
* Negative human chorionic gonadotropin (HCG) in the 7 days preceding the inclusion for women in age of procreation.
* Membership of the French national insurance.
Exclusion Criteria:
* Grade \>II acute GVHD or chronic extensive GVHD at the time of inclusion.
* Patient receiving an immunosuppressive treatment for GVHD treatment at the time of inclusion.
* Dysfunction of liver (alanine aminotransferase / aspartate transaminase (ALAT/ASAT) \> 5 N, or bilirubin \> 50 µM), or of the renal function (creatinine clearance \< 30 ml / min).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01086735
Study Brief:
Protocol Section:
NCT01086735